Ligand Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
15,979.00
167,336.00
200,219.00
141,048.00
201,661.00
767
Total Accounts Receivable
6,724.00
13,641.00
11,683.00
18,218.00
29,970.00
56
Inventories
1,392.00
269.00
1,633.00
1,923.00
4,373.00
7
Other Current Assets
786.00
3,103.00
1,177.00
1,864.00
1,017.00
40
Total Current Assets
24,881.00
184,349.00
214,712.00
163,053.00
237,021.00
871
Net Property, Plant & Equipment
867.00
486.00
372.00
1,819.00
4,212.00
5
Total Investments and Advances
1,341.00
1,261.00
29,728.00
8,345.00
6,438.00
-
Long-Term Note Receivable
7,417.00
-
-
-
-
-
Intangible Assets
69,908.00
67,529.00
69,139.00
302,733.00
334,069.00
338
Other Assets
299.00
4,404.00
27.00
1,744.00
4,859.00
-
Total Assets
104,713.00
258,029.00
503,061.00
601,585.00
722,652.00
1,313
ST Debt & Current Portion LT Debt
9,109.00
334.00
201,985.00
212,910.00
224,529.00
Accounts Payable
3,951.00
7,698.00
4,083.00
2,734.00
2,259.00
Income Tax Payable
1,574.00
257.00
-
-
-
Other Current Liabilities
14,305.00
14,490.00
16,753.00
11,485.00
12,080.00
Total Current Liabilities
28,939.00
22,779.00
222,821.00
227,129.00
238,868.00
Long-Term Debt
-
195,908.00
39,628.00
29,563.00
18,859.00
Provision for Risks & Charges
11,795.00
8,353.00
3,033.00
2,916.00
-
Deferred Taxes
1,098.00
2,792.00
189,083.00
123,891.00
84,422.00
Other Liabilities
13,268.00
3,789.00
297.00
687.00
13,506.00
Total Liabilities
55,100.00
233,621.00
265,779.00
260,295.00
322,864.00
Common Equity (Total)
49,613.00
26,318.00
237,282.00
341,290.00
399,788.00
Total Shareholders' Equity
49,613.00
26,318.00
237,282.00
341,290.00
399,788.00
Total Equity
49,613.00
24,408.00
237,282.00
341,290.00
399,788.00
Liabilities & Shareholders' Equity
104,713.00
258,029.00
503,061.00
601,585.00
722,652.00
Accumulated Minority Interest
-
1,910.00
-
-
-
About Ligand Pharmaceuticals
View Profile
